Carmen Aguilera

869 total citations
22 papers, 302 citations indexed

About

Carmen Aguilera is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Carmen Aguilera has authored 22 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Pathology and Forensic Medicine and 7 papers in Oncology. Recurrent topics in Carmen Aguilera's work include Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Carmen Aguilera is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Carmen Aguilera collaborates with scholars based in Spain and United States. Carmen Aguilera's co-authors include Enrique M. Ocio, Jesús F. San Miguel, Jesús María Hernández‐Rivas, Manuel Moro, Abelardo Bárez, J. A. Portero, María‐Belén Vídriales, Javier García‐Frade, L. Escribano and Rafael López Castro and has published in prestigious journals such as Blood, British Journal of Haematology and Leukemia.

In The Last Decade

Carmen Aguilera

18 papers receiving 290 citations

Peers

Countries citing papers authored by Carmen Aguilera

Since Specialization

Citations

This map shows the geographic impact of Carmen Aguilera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Aguilera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Aguilera more than expected).

Fields of papers citing papers by Carmen Aguilera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Aguilera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Aguilera. The network helps show where Carmen Aguilera may publish in the future.

Co-authorship network of co-authors of Carmen Aguilera

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Aguilera. A scholar is included among the top collaborators of Carmen Aguilera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Aguilera. Carmen Aguilera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Analysis of periodontitis severity and associated factors in patients from a periodontology clinic in Durango, Meacute;xico: A retrospective descriptive study 2025 ·International Journal of Applied Dental Sciences ·Carmen Aguilera, (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem‐cell transplantation is a prognostic marker of longer progression‐free survival and overall survival 2022 ·British Journal of Haematology ·Julio Dávila, Verónica González‐Calle, Fernando Escalante, (unknown), Noemí Puig, Ramón García‐Sánz, Abelardo Bárez, Carmen Montes, (unknown), José María Alonso, Carlos Aguilar, Aránzazu García‐Mateo, Jorge Labrador, Carmen Aguilera, (unknown), Roberto Sosa Hernández, María‐Victoria Mateos, Enrique M. Ocio	5
3	Long‐term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first‐line therapy: A retrospective analysis from two institutions 2019 ·European Journal Of Haematology ·Santiago Mercadal, Juan‐Manuel Sancho, Fina Climent, Gustavo Tapia, Helena Pomares, (unknown), Marc Sorigué, (unknown), Eva Domingo‐Doménech, Maite Encuentra, Carmen Aguilera, Ana Carla Oliveira, (unknown), Alberto Fernández de Sevilla, Josep‐María Ribera, Eva González‐Barca, Anna Sureda	3
4	Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL): results in a homogeneous series from a single institution 2019 ·Biomarkers ·María Queralt Salas, Fina Climent, Gustavo Tapia, Eva Domingo‐Doménech, Santiago Mercadal, Ana Carla Oliveira, Carmen Aguilera, (unknown), (unknown), Marcio Andrade‐Campos, Maite Encuentra, Alberto Fernández de Sevilla, Anna Sureda, Juan‐Manuel Sancho, Eva González‐Barca	13
5	Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution 2019 ·Leukemia & lymphoma ·María Queralt Salas, Santiago Mercadal, Eva Domingo‐Doménech, Ana Carla Oliveira, Maite Encuentra, Fina Climent, (unknown), Carmen Aguilera, Alberto Fernández de Sevilla, Anna Sureda, Eva González‐Barca	5
6	PO-1089: IORT for breast cancer treated with Axxent Xoft. Our experience: toxicity analysis 2018 ·Radiotherapy and Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Iria Gómez, (unknown), Carmen Aguilera, (unknown)	2
7	Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma 2017 ·Haematologica ·Verónica González‐Calle, (unknown), Jorge Labrador, (unknown), (unknown), Carmen Aguilera, Enrique M. Ocio, María‐Belén Vídriales, Noemí Puig, Norma C. Gutiérrez, Ramón García‐Sánz, José María Alonso, (unknown), Carlos Aguilar, Alfonso García de Coca, Roberto Sosa Hernández, (unknown), Fernando Escalante, María‐Victoria Mateos	27
8	CD30 expression in diffuse large B‐cell lymphoma correlates with non‐GCB subtype but does not have prognostic impact in patients treated with first line R‐CHOP/R‐CHOP–like 2017 ·Hematological Oncology ·(unknown), Fina Climent, Gustavo Tapia, (unknown), Santiago Mercadal, Eva Domingo‐Doménech, Ana Carla Oliveira, (unknown), Olga García, Carmen Aguilera, Alberto Fernández de Sevilla, Anna Sureda, Juan‐Manuel Sancho, Eva González‐Barca	1
9	Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma 2016 ·Leukemia ·Verónica González‐Calle, Julio Dávila, Fernando Escalante, Alfonso García de Coca, Carmen Aguilera, Rafael López, Abelardo Bárez, José María Alonso, Roberto Sosa Hernández, (unknown), P. de la Fuente, Noemí Puig, Enrique M. Ocio, Norma C. Gutiérrez, Ramón García‐Sánz, María‐Victoria Mateos	14
10	CD30 Expression in Diffuse Large B-Cell Lymphoma (DLBCL) Correlates with Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated with First Line R-CHOP/R-CHOP-like 2016 ·Blood ·María Queralt Salas, Fina Climent, Eva Domingo‐Doménech, Santiago Mercadal, (unknown), Ana Carla Oliveira, Carmen Aguilera, (unknown), Anna Lucas, Nadia García, (unknown), Alberto Fernández de Sevilla, Anna Sureda, Eva González‐Barca, (unknown)	2
11	Immunoparesis Recovery as Predictor Marker of Progression After Autologous Stem Cell Transplantation in Multiple Myeloma 2015 ·Clinical Lymphoma Myeloma & Leukemia ·Verónica González‐Calle, (unknown), Julio Dávila, Enrique M. Ocio, Noemí Puig, Norma C. Gutiérrez, Ramón García‐Sánz, Alfonso García de Coca, (unknown), Roberto Sosa Hernández, Abelardo Bárez, José María Alonso, Carmen Aguilera, Fernando Escalante, Guillermo Martı́n, Rafael López, P. de la Fuente, Jorge Labrador, Carlos Aguilar, MV Mateos	1
12	Immunoparesis Recovery As Predictor Marker of Progression after Autologous Stem Cell Transplantation in Multiple Myeloma 2015 ·Blood ·Verónica González‐Calle, (unknown), Julio Dávila, Enrique M. Ocio, Noemí Puig, Norma C. Gutiérrez, Ramón García‐Sánz, Alfonso García de Coca, (unknown), Roberto Sosa Hernández, Abelardo Bárez, José María Alonso, Carmen Aguilera, Fernando Escalante, Guillermo Martı́n, (unknown), (unknown), Jorge Labrador, Carlos Aguilar, María‐Victoria Mateos	2
13	Bence Jones Proteinuria in Smoldering Multiple Myeloma As Predictor Marker of Progression to Symptomatic Multiple Myeloma 2014 ·Blood ·Verónica González‐Calle, Ramón García‐Sánz, (unknown), Enrique M. Ocio, Noemí Puig, Norma C. Gutiérrez, (unknown), (unknown), Alfonso García de Coca, José M. Hernández, Roberto Sosa Hernández, Abelardo Bárez, José María Alonso, Carmen Aguilera, Fernando Escalante, Guillermo Martı́n, (unknown), (unknown), María‐Victoria Mateos	4
14	6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis 2006 ·British Journal of Haematology ·Enrique M. Ocio, Roelandt F.J. Schop, (unknown), Scott A. Van Wier, Jesús María Hernández‐Rivas, Norma C. Gutiérrez, Ramón García‐Sánz, Manuel Moro, Carmen Aguilera, (unknown), Philip R. Greipp, Angela Dispenzieri, S. M. Jalal, Martha Q. Lacy, Natalia González-Paz, Morie A. Gertz, Jesús F. San Miguel, Rafaël Fonseca	69
15	Myxoma of the renal capsule 2005 ·Pathology - Research and Practice ·J. Fernando Val‐Bernal, Carmen Aguilera, Nuria T. Villagrá, (unknown)	8
16	6q Deletion in Waldenstrom Macroglobulinemia Is the Most Common Cytogenetic Abnormality and Is Associated with Aggressive Disease with a Trend towards Worse Survival. 2005 ·Blood ·Roelandt F.J. Schop, Enrique M. Ocio, (unknown), Norma C. Gutiérrez, Marı́a Jesús Moro, Carmen Aguilera, José‐Ángel Hernández‐Rivas, Ramón García‐Sánz, Ruifang Xu, Jesús María Hernández‐Rivas, Philip R. Greipp, Angela Dispenzieri, Syed M. Jalal, Martha Q. Lacy, Natalia González-Paz, Morie A. Gertz, Jesús F. San Miguel, Rafaël Fonseca	1
17	Xochipilli dios solar 2004 ·Repositorio Institucional Históricas-UNAM (Universidad Nacional Autónoma de México. Instituto de Investigaciones Históricas) ·Carmen Aguilera	2
18	Bone remodelation markers are useful in the management of monoclonal gammopathies 2004 ·The Hematology Journal ·José M. Hernández, (unknown), José Antonio Queizán, Rosa Fisac, (unknown), (unknown), Ramón García‐Sánz, (unknown), Abelardo Bárez, María José Calmuntia, Javier García‐Frade, J. A. Portero, (unknown), Carmen Aguilera, J.A. Navajo, Jesús F. San Miguel	12
19	Immunophenotypic analysis of Waldenstrom's macroglobulinemia 2003 ·Seminars in Oncology ·Jesús F. San Miguel, María‐Belén Vídriales, Enrique M. Ocio, Gema Mateo, Fermín Sánchez‐Guijo, María Luz Sánchez, L. Escribano, Abelardo Bárez, Manuel Moro, Jesús María Hernández‐Rivas, Carmen Aguilera, Rebeca Cuello, Javier García‐Frade, Rafael López Castro, J. A. Portero, (unknown)	127
20	The Matrícula de Huexotzinco: A Pictorial Census from New Spain 1996 ·Huntington Library Quarterly ·Carmen Aguilera	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact